Literature DB >> 10738870

Hemangioma of skeletal muscle.

A T Wild1, P Raab, R Krauspe.   

Abstract

Intramuscular hemangiomas are rare benign tumors, making up 0.8% of all hemangiomas. They are of interest to the surgeon because their location may present considerable therapeutic challenge since radiographic work-up of the soft- tissue mass by magnetic resonance imaging (MRI) may be suspicious for malignancy. The definitive diagnosis is made by histological study of the surgical and/or biopsy specimen. Patients with intramuscular hemangiomas may have soft-tissue complaints, such as pain and swelling, present for years. The gross and microscopic appearance of intramuscular hemangiomas is variable. Grossly, the capillary type is nonvascular and spongy in appearance, whereas the cavernous type is composed of large, thin-walled, dilated vessels lined by flattened endothelial cells. In general, wide excision is the treatment of choice to prevent local recurrence, but every patient with intramuscular hemangioma should be treated individually after evaluating the tumor location, accessibility, and depth of invasion, the patient's age, and cosmetic considerations. From October 1, 1989, to June 30, 1997, 11 patients underwent surgical treatment with the definitive histological diagnosis of intramuscular hemangioma. Pain upon activity but also at rest as well as swelling were the major symptoms. The average duration of symptoms was 13 months (range 1 month to 5 years). After a mean follow- up of 3 years and 4 months (range 12 months to 9 years), one of the patients has developed a recurrence; all remaining patients enjoy pain relief without any recurrence.

Entities:  

Mesh:

Year:  2000        PMID: 10738870     DOI: 10.1007/pl00013761

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  26 in total

1.  Cavernous hemangioma atypically located at the left brachial region.

Authors:  Omer Tetik; Ufuk Yetkin; Turkan Rezanko; Barcin Ozcem; Ali Gurbuz
Journal:  Tex Heart Inst J       Date:  2008

2.  Intramuscular Arteriovenous Hemangioma of Thigh: A Case Report and Review of Literature.

Authors:  Sanjeev Patnaik; Praveen Kumar; Biswaranjan Nayak; Nachiketa Mohapatra
Journal:  J Orthop Case Rep       Date:  2016 Nov-Dec

Review 3.  Imaging of head and neck venous malformations.

Authors:  Christine M Flis; Stephen E Connor
Journal:  Eur Radiol       Date:  2005-07-08       Impact factor: 5.315

4.  Tendon Sheath Hemangioma.

Authors:  Tushar Ranjan Dalei; Vijay Kumar Loya
Journal:  J Hand Microsurg       Date:  2018-06-20

5.  Quiescent Volcano-Chest Wall Hemangioma.

Authors:  Elroy Saldanha; John J S Martis; B Vinod Kumar; Rithesh J D'Cunha; V Vijin
Journal:  Indian J Surg       Date:  2016-10-19       Impact factor: 0.656

6.  MRI manifestations of soft-tissue haemangiomas and accompanying reactive bone changes.

Authors:  A Pourbagher; M A Pourbagher; B Karan; G Ozkoc
Journal:  Br J Radiol       Date:  2010-12-01       Impact factor: 3.039

Review 7.  The role of the plain radiograph in the characterisation of soft tissue tumours.

Authors:  Louise Gartner; Christopher J Pearce; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2008-06-20       Impact factor: 2.199

8.  Misdiagnosis of pathological femoral fracture in a patient with intramuscular hemangioma: A case report.

Authors:  Xiaolong Yu; Tao Nie; Bin Zhang; Min Dai; Hucheng Liu; Fan Zou
Journal:  Oncol Lett       Date:  2016-05-18       Impact factor: 2.967

Review 9.  The histological variants of liposarcoma: predictive MRI findings with prognostic implications, management, follow-up, and differential diagnosis.

Authors:  Magda Rizer; Adam D Singer; Mark Edgar; Jean Jose; Ty K Subhawong
Journal:  Skeletal Radiol       Date:  2016-05-21       Impact factor: 2.199

10.  Ethanol sclerotherapy reduces pain in symptomatic musculoskeletal hemangiomas.

Authors:  Eileen A Crawford; Rachel L Slotcavage; Joseph J King; Richard D Lackman; Christian M Ogilvie
Journal:  Clin Orthop Relat Res       Date:  2009-06-18       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.